Internship: GSK Master Internship for Advanced Characterization of mRNA Vaccines in the Sizing & Morphology Platform, Belgium – 2024
GlaxoSmithKline
Rixensart, Waals Brabant
Training
Voltijds
1 maand geleden
Internship: GSK Master Internship for Advanced Characterization of mRNA Vaccines in the Sizing & Morphology Platform, Belgium – 2024Help us get ahead of disease together with our Internship ProgramEducation required: You are regularly enrolled in a Master in: Molecular/Cellular Biology, Chemistry, Biochemistry, Biophysics, Biology, Bioengineering, Chemical Engineering, Pharmacy, or other relevant disciplines in an Educational Establishment located in Europe.Language requirement: • Fluency in French (native language of the team) and EnglishExpected start date: As soon as possible.Duration: 3 to 6 monthsWork arrangements: HybridRequisite: The internship must be mandatory & done in the framework of the curriculum, for which an agreement must be signed between GSK, the student, and the Educational Establishment.Remuneration: according to Belgian legal requirements, the internship will not be paid. However, some expenses will be reimbursed.Application deadline: We will close this vacancy when we have enough applications, so please apply as soon as you can to be considered.Looking to gain valuable real world work experience and help positively impact the health of billions of people? Apply for a GSK Internship today!A GSK internship offers you the opportunity to kickstart your career – to take on a real role with genuine impact! You’ll take on challenging, serious work on live projects or assignments. You’ll also get to learn from us, develop your skills and gain valuable experience for wherever the future takes you.What will you do?As an intern within the Sizing & Morphology platform in Analytical R&D (ARD), your role will be to explore, create and develop advanced characterization methods for new mRNA vaccine projects to strengthen and expand the current knowledge of the vaccine technology.The Sizing & Morphology platform is responsible for the characterization of a wide range of vaccine attributes using various imagery-based and size-based technologies. The techniques comprise:MicroscopyElectron Microscopy (Cryo-TEM, NS, SEM), confocal microscopyNanoparticle tracking techniquesNTA, NanoFCMSizing techniques,AF4-MALS, DLS/MADLSYour role will be key in the development of these advanced characterization techniques, and you will be responsible in the team to support the project and communicate the outcomes.Your responsibilities:
You will develop methods in collaboration with team members in the laboratories located on the Rixensart site.
You will maintain knowledge of the scientific literature/technological advances related to the mRNA vaccines.
You will generate, interpret, and report results to the team and participate in team meetings.
You will be involved in generating appropriate analytical documentation, including protocols and reports.
You will present results at internal meetings (within the team and analytical sub teams, etc.).
What are we looking for?
Sound scientific methodology and thinking, commitment to solving problems and bringing innovative solutions to the team.
Excellent oral & written communication skills, ability to engage the team, result- and quality-oriented open mind.
A background in chemistry, biology, or related subject.
Knowledge in good laboratory practices and experience in a “wet” lab.
Ideally, awareness of at least one of the analytical techniques listed above.
Let’s do this!You’ll find hints, tips and guidance on our recruitment process on our website –Apply now!We recommend you apply as soon as possible, because we accept ongoing applications and offer positions on a first come, first served basis.#Li-GSKIf you have a disability and require assistance during the course of the selection process, you will have the opportunity to let us know what specific assistance you require in order to make suitable arrangements.Why Us?GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organization where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to positively impact the health of 2.5 billion people by the end of 2030.Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a workplace where everyone can feel a sense of belonging and thrive as set out in our Equal and Inclusive Treatment of Employees policy. We’re committed to being more proactive at all levels so that our workforce reflects the communities we work and hire in, and our GSK leadership reflects our GSK workforce.Important notice to Employment businesses/ AgenciesGSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.
